Cellcom Israel Ltd. (OTCMKTS:CELJF - Get Free Report) shares hit a new 52-week high during trading on Wednesday . The company traded as high as $7.49 and last traded at $6.97, with a volume of 200 shares traded. The stock had previously closed at $7.00.
Analyst Upgrades and Downgrades
Separately, Barclays lowered Cellcom Israel from a "hold" rating to a "strong sell" rating in a research note on Tuesday, January 28th.
Check Out Our Latest Stock Report on CELJF
Cellcom Israel Price Performance
The stock has a 50 day simple moving average of $6.18 and a two-hundred day simple moving average of $5.01. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.60 and a current ratio of 0.65.
About Cellcom Israel
(
Get Free Report)
Cellcom Israel Ltd. provides cellular communications services in Israel. It operates in two segments, Cellular and Fixed-line. The Cellular segment offers cellular communications, and cellular equipment and related services. The Fixed-line segment provides infrastructure and internet access, internet-based television, international telephony, landline telephony services, and transmission services for business customers and for telecommunication operators; and conferencing, cloud computing, and server hosting services, as well as IOT solutions.
Featured Articles
Before you consider Cellcom Israel, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cellcom Israel wasn't on the list.
While Cellcom Israel currently has a "Sell" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
